Nabiqasim Industries
CompanyPakistan
Nabiqasim Industries develops one asset, approved (resmetirom in fibrosis). Mostly small molecule acting on Mitochondrial biogenesis (PGC-1α), lipid and ceramide metabolism and THRB; based in Pakistan.
- 1
- Asset
- Furthest stage
- Approved
- 2
- Trials
- 3
- Signals
Pipeline
1Selective thyroid hormone receptor beta agonist that reduces hepatic fat accumulation
Approved, Small molecule, Mitochondrial biogenesis (PGC-1α), Lipid and ceramide metabolism, fibrosis, liver cirrhosis
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms4
- Trials2
- Signals4
- Similar companies6